Nektar Therapeutics (NKTR) Total Debt Growth (3y) (2014 - 2020)
Nektar Therapeutics (NKTR) Total Debt Growth (3y) (2014 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.08% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.52% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.76% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.30% |
| 10 | Nektar Therapeutics | 1.49 Bn | 919.46 Mn | 3.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 27.79% |
| Dec 31, 2019 | 1.27% |
| Sep 30, 2019 | 0.72% |
| Jun 30, 2019 | 0.72% |
| Mar 31, 2019 | 0.72% |
| Dec 31, 2018 | 0.72% |
| Sep 30, 2018 | 25.40% |
| Jun 30, 2018 | 25.33% |
| Mar 31, 2018 | 25.26% |
| Dec 31, 2017 | 25.18% |
| Sep 30, 2017 | 25.11% |
| Jun 30, 2017 | 25.03% |
| Mar 31, 2017 | 24.96% |
| Dec 31, 2016 | 24.88% |
| Sep 30, 2016 | 24.81% |
| Jun 30, 2016 | 24.73% |
| Mar 31, 2016 | 24.66% |
| Dec 31, 2015 | 24.58% |
| Sep 30, 2015 | 0.00% |
| Mar 31, 2015 | -16.53% |